Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

402

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 29, 2014

Study Completion Date

January 29, 2014

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

Placebo

DRUG

Vilazadone

Viibryd

Trial Locations (30)

18104

Forest Investigative Site 014, Allentown

19139

Forest Investigative Site 015, Philadelphia

32256

Forest Investigative Site 002, Jacksonville

32806

Forest Investigative Site 001, Orlando

33015

Forest Investigative Site 024, Miami

33067

Forest Investigative Site 017, Coral Springs

33912

Forest Investigative Site 028, Fort Myers

34748

Forest Investigative Site 020, Leesburg

38119

Forest Investigative Site 006, Memphis

43210

Forest Investigative Site 031, Columbus

44718

Forest Investigative Site 003, Canton

45040

Forest Investigative Site 021, Mason

46260

Forest Investigative Site 026, Indianapolis

71104

Forest Investigative Site 029, Shreveport

73112

Forest Investigative Site 030, Oklahoma City

77054

Forest Investigative Site 008, Houston

77096

Forest Investigative Site 018, Houston

84123

Forest Investigative Site 011, Murray

89102

Forest Investigative Site 019, Las Vegas

90210

Forest Investigative Site 023, Beverly Hills

91007

Forest Investigative Site 022, Arcadia

91316

Forest Investigative Site 010, Encino

91403

Forest Investigative Site 007, Sherman Oaks

91786

Forest Investigative Site 012, Upland

92374

Forest Investigative Site 004, Redlands

92562

Forest Investigative Site 016, Temecula

92660

Forest Investigative Site 025, Newport Beach

97301

Forest Investigative Site 005, Salem

02865

Forest Investigative Site 027, Lincoln

05091

Forest Investigative Site 013, Woodstock

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY